Indiana University Health
Director of Malignant Hematology Program
Indiana University Health, Indianapolis, Indiana, us, 46262
Overview
The Director of the Malignant Hematology Program will be responsible for providing strategic direction and leadership across our comprehensive portfolio of hematologic malignancy programs. The successful candidate will oversee clinical operations for 13 disease-focused subspecialty programs, ensure excellence in multidisciplinary patient care, and spearhead research initiatives that advance the field of malignant hematology. This role presents an exceptional opportunity to build upon our robust clinical and research infrastructure, collaborating with faculty and university leaders to support our integrated academic, research, and clinical missions. Location: Indianapolis, IN Salary and benefits: (as posted) Responsibilities
Lead and manage the comprehensive Malignant Hematology Program encompassing 13 disease-focused subspecialty areas across Indiana University Health's academic medical centers Collaborate closely with the Hematopoiesis and Hematological Malignancies (HHM) Research Program at IUSCCC to advance translational research initiatives Work in strategic partnership with the Brown Center for Immunotherapy at Indiana University Melvin and Bren Simon Comprehensive Cancer Center to integrate novel cellular therapy approaches for treatment Develop and implement strategic initiatives to enhance patient outcomes, expand clinical trial portfolios, and establish disease-specific programs as regional and national referral centers Provide clinical oversight and academic guidance to multidisciplinary teams, subspecialty faculty, fellows, residents, and advanced practice providers while mentoring junior faculty Expand the research portfolio with emphasis on investigator-initiated clinical trials, cooperative group studies, and translational research spanning the spectrum of hematologic malignancies Serve as liaison with external partners, pharmaceutical industry, cooperative groups, and national cancer networks to develop collaborative research opportunities and enhance the program's national prominence Foster interdisciplinary collaboration among the 13 disease-focused programs to promote knowledge sharing and optimize patient care delivery Qualifications
MD, DO, or equivalent degree with BC in Hem/Onc, with demonstrated expertise across multiple hematologic malignancies 5+ years of experience leading clinical, translational, and/or basic research programs in malignant hematology, along with an independent, extramurally funded research program (e.g., NIH R01, cooperative group leadership, or industry-sponsored investigational studies) Demonstrate substantial academic productivity with 5+ years of peer-reviewed publications in hematologic malignancies, along with evidence of successful grant acquisition and research program leadership across multiple disease areas Mid to senior-level faculty experience required, with demonstrated leadership capabilities in academic medicine and program development Practice Structure
Academic Distribution: 55% Clinical and 45% Academic focus, supporting both patient care excellence and scholarly activities Clinical Practice: Comprehensive academic practice encompassing clinical care, research, and education across multiple hematologic malignancy subspecialties Program Scope: Practice comprised of hematology/oncology subspecialists organized into 13 disease-focused programs covering the full spectrum of blood cancers Practice Locations: University Hospital, Eskenazi Hospital, IU Simon Comprehensive Cancer Center, and affiliated academic medical centers Community Description
Leading educational system and top-ranked universities, paired with a diverse population Vibrant downtown offering arts, theaters, world-class museums, zoo, concerts and memorials Named to U.S. News & World Report's 2023-2024 list of the best places to live in the United States Top ranked international airport: Best Airport in North America (twelve consecutive years) Ranked by Niche in 2023 as one of the most diverse counties in America, as well as one of the best cities to live in and buy a house in the country Historic neighborhoods with surrounding cultural districts and low cost of living Outdoor recreation includes golfing, boating and unique parks Home of professional teams and major events including the Colts, Fever, Pacers, Indians, and the Indianapolis 500 Close proximity to Chicago, St. Louis, Louisville, and Cincinnati Healthcare System/Hospital Description
The IU Health Melvin and Bren Simon Cancer Center offers high-level patient care and is engaged in research. It is the only National Cancer Institute (NCI)-designated cancer center in Indiana, with multidisciplinary cancer research programs and facilities. In 2022, IU Health Simon Cancer Center joined the National Comprehensive Cancer Network (NCNN), an alliance of 32 leading cancer centers devoted to patient care, research and education. The mission is to advance understanding, prevention and treatment of cancer through patient-centered care, accelerated science, and collaborative education. More than 200 physicians, nurses, social workers, technologists and researchers collaborate to develop cures for cancer. Seniority level
Director Employment type
Full-time Indianapolis, IN
#J-18808-Ljbffr
The Director of the Malignant Hematology Program will be responsible for providing strategic direction and leadership across our comprehensive portfolio of hematologic malignancy programs. The successful candidate will oversee clinical operations for 13 disease-focused subspecialty programs, ensure excellence in multidisciplinary patient care, and spearhead research initiatives that advance the field of malignant hematology. This role presents an exceptional opportunity to build upon our robust clinical and research infrastructure, collaborating with faculty and university leaders to support our integrated academic, research, and clinical missions. Location: Indianapolis, IN Salary and benefits: (as posted) Responsibilities
Lead and manage the comprehensive Malignant Hematology Program encompassing 13 disease-focused subspecialty areas across Indiana University Health's academic medical centers Collaborate closely with the Hematopoiesis and Hematological Malignancies (HHM) Research Program at IUSCCC to advance translational research initiatives Work in strategic partnership with the Brown Center for Immunotherapy at Indiana University Melvin and Bren Simon Comprehensive Cancer Center to integrate novel cellular therapy approaches for treatment Develop and implement strategic initiatives to enhance patient outcomes, expand clinical trial portfolios, and establish disease-specific programs as regional and national referral centers Provide clinical oversight and academic guidance to multidisciplinary teams, subspecialty faculty, fellows, residents, and advanced practice providers while mentoring junior faculty Expand the research portfolio with emphasis on investigator-initiated clinical trials, cooperative group studies, and translational research spanning the spectrum of hematologic malignancies Serve as liaison with external partners, pharmaceutical industry, cooperative groups, and national cancer networks to develop collaborative research opportunities and enhance the program's national prominence Foster interdisciplinary collaboration among the 13 disease-focused programs to promote knowledge sharing and optimize patient care delivery Qualifications
MD, DO, or equivalent degree with BC in Hem/Onc, with demonstrated expertise across multiple hematologic malignancies 5+ years of experience leading clinical, translational, and/or basic research programs in malignant hematology, along with an independent, extramurally funded research program (e.g., NIH R01, cooperative group leadership, or industry-sponsored investigational studies) Demonstrate substantial academic productivity with 5+ years of peer-reviewed publications in hematologic malignancies, along with evidence of successful grant acquisition and research program leadership across multiple disease areas Mid to senior-level faculty experience required, with demonstrated leadership capabilities in academic medicine and program development Practice Structure
Academic Distribution: 55% Clinical and 45% Academic focus, supporting both patient care excellence and scholarly activities Clinical Practice: Comprehensive academic practice encompassing clinical care, research, and education across multiple hematologic malignancy subspecialties Program Scope: Practice comprised of hematology/oncology subspecialists organized into 13 disease-focused programs covering the full spectrum of blood cancers Practice Locations: University Hospital, Eskenazi Hospital, IU Simon Comprehensive Cancer Center, and affiliated academic medical centers Community Description
Leading educational system and top-ranked universities, paired with a diverse population Vibrant downtown offering arts, theaters, world-class museums, zoo, concerts and memorials Named to U.S. News & World Report's 2023-2024 list of the best places to live in the United States Top ranked international airport: Best Airport in North America (twelve consecutive years) Ranked by Niche in 2023 as one of the most diverse counties in America, as well as one of the best cities to live in and buy a house in the country Historic neighborhoods with surrounding cultural districts and low cost of living Outdoor recreation includes golfing, boating and unique parks Home of professional teams and major events including the Colts, Fever, Pacers, Indians, and the Indianapolis 500 Close proximity to Chicago, St. Louis, Louisville, and Cincinnati Healthcare System/Hospital Description
The IU Health Melvin and Bren Simon Cancer Center offers high-level patient care and is engaged in research. It is the only National Cancer Institute (NCI)-designated cancer center in Indiana, with multidisciplinary cancer research programs and facilities. In 2022, IU Health Simon Cancer Center joined the National Comprehensive Cancer Network (NCNN), an alliance of 32 leading cancer centers devoted to patient care, research and education. The mission is to advance understanding, prevention and treatment of cancer through patient-centered care, accelerated science, and collaborative education. More than 200 physicians, nurses, social workers, technologists and researchers collaborate to develop cures for cancer. Seniority level
Director Employment type
Full-time Indianapolis, IN
#J-18808-Ljbffr